United States · FDA National Drug Code directory
Spironolactone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69584-852_70be7336-8f41-4960-b57d-7830ca020481
- Product NDC
- 69584-852
- Form
- TABLET, COATED
- Composition / generic term
- Spironolactone
- Labeler
- Oxford Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210104
- Source listing expiry
- 20271231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, COATED in 1 BOTTLE (69584-852-09) · 69584-852-09
- 100 TABLET, COATED in 1 BOTTLE (69584-852-10) · 69584-852-10
- 500 TABLET, COATED in 1 BOTTLE (69584-852-50) · 69584-852-50
- 1000 TABLET, COATED in 1 BOTTLE (69584-852-90) · 69584-852-90
- 2500 TABLET, COATED in 1 BOTTLE (69584-852-92) · 69584-852-92
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →